Metraipolis › archive › dc_6914deceae72

Enhanced adenoviral reactivity in Guillain-Barré syndrome after SARS-CoV-2 infection and vaccination — Europe PMC PMID:41055073

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41055073
DOI
10.1093/brain/awaf376
License (as archived)
solo-consultazione
Archived
2026-11-02T22:26:52.108Z
SHA-256 of the archived text
cf683c6f0212155c1c53d5007ffeffa874eb19eaf4f9bb6c30eea4b7c55be7ed
Stable URL of this page
https://metraipolis.com/documento/dc_6914deceae72

How to cite

Enhanced adenoviral reactivity in Guillain-Barré syndrome after SARS-CoV-2 infection and vaccination — Europe PMC PMID:41055073 — Europe PMC (en), https://europepmc.org/article/MED/41055073 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6914deceae72 (Metraipolis archive dc_6914deceae72, sha256 cf683c6f0212155c1c53d5007ffeffa874eb19eaf4f9bb6c30eea4b7c55be7ed)
BibTeX
@misc{dc6914deceae72,
  title = {Enhanced adenoviral reactivity in Guillain-Barré syndrome after SARS-CoV-2 infection and vaccination — Europe PMC PMID:41055073},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41055073},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6914deceae72; sha256 cf683c6f0212155c1c53d5007ffeffa874eb19eaf4f9bb6c30eea4b7c55be7ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41055073. Agents can read the archived copy with the MCP tool read_document.